Eterna Therapeutics financial statements

어넥사 테라퓨틱스NASDAQ:ERNA · Nasdaq · Healthcare · sector #17
$2.23-17.22%
2026-10-06 close

Eterna Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $1M. 2024 operating profit was −$38M.

Reported results

Eterna Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q